Related references
Note: Only part of the references are listed.Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker et al.
CIRCULATION RESEARCH (2021)
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker et al.
LANCET (2021)
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Paul M. Ridker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of interleukin-6 with aortic stiffness in end-stage renal disease
Marie-Pier Desjardins et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2018)
Chronic inflammation in end-stage renal disease and dialysis
Gabriela Cobo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Adipokines and severity and progression of coronary artery calcium: Findings from the Rancho Bernardo Study
Britta A. Larsen et al.
ATHEROSCLEROSIS (2017)
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Jia Sun et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
Abdullah Ozkok et al.
BMC NEPHROLOGY (2013)
FGF-23 and the Progression of Coronary Arterial Calcification in Patients New to Dialysis
Abigail May Khan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients
Christiaan L. Meuwese et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Total and Individual Coronary Artery Calcium Scores as Independent Predictors of Mortality in Hemodialysis Patients
Ronney S. Shantouf et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination
Alberto Radaelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?
Carmine Zoccali et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis
Hae Hyuk Jung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
H Honda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
DV Barreto et al.
KIDNEY INTERNATIONAL (2005)
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients
M Rao et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Evaluating changes in coronary artery calcium: An analytic method that accounts for interscan variability
JE Hokanson et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inflammation as a cardiovascular risk factor
JT Willerson et al.
CIRCULATION (2004)
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
R Pecoits-Filho et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients:: Association with Chlamydia pneumoniae seropositivity
P Stenvinkel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men
SE Humphries et al.
EUROPEAN HEART JOURNAL (2001)
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
J Blacher et al.
HYPERTENSION (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)